JANICOT; Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for JANICOT; Michel.The latest application filed is for "new treatments involving mirna-193a".

Company Profile

5.6.11

JANICOT; Michel - Brussels BE
JANICOT; Michel - Uccle BE
Janicot; Michel - Munich DE
JANICOT; Michel - Munchen DE
Janicot; Michel - Brussles BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Treatments Involving Mirna-193a App 20220275368 - YAHYANEJAD; Sanaz ; et al.	2022-09-01
Nr2e3 Expression Reducing Oligonucleotides, Compositions Containing The Same, And Methods Of Their Use App 20220098595 - SEWACK; Gerald ; et al.	2022-03-31
TGF-beta oligonucleotide for use in treatment of ophthalmic diseases Grant 11,207,341 - Leo , et al. December 28, 2	2021-12-28
Anticancer Microrna And Lipid Formulations Thereof App 20210038732 - DE GUNST; Matheus Maria ; et al.	2021-02-11
Modified TGF-beta oligonucleotides Grant 10,538,768 - Jaschinski , et al. Ja	2020-01-21
Tgf-beta Oligonucleotide For Use In Treatment Of Ophthalmic Diseases App 20190262384 - LEO; Eugen ; et al.	2019-08-29
Modified Tgf-beta Oligonucleotide For Use In A Method Of Preventing And/or Treating An Ophthalmic Disease App 20190144865 - JASCHINSKI; Frank ; et al.	2019-05-16
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease Grant 10,125,368 - Jaschinski , et al. November 13, 2	2018-11-13
Modified Tgf-beta Oligonucleotides App 20180230473 - JASCHINSKI; Frank ; et al.	2018-08-16
Modified Tgf-beta2 Oligonucleotides App 20180087055 - Jaschinski; Frank ; et al.	2018-03-29
Modified TGF-beta oligonucleotides Grant 9,926,563 - Jaschinski , et al. March 27, 2	2018-03-27
Modified TGF-beta2 oligonucleotides Grant 9,840,707 - Jaschinski , et al. December 12, 2	2017-12-12
Modified Tgf-beta Oligonucleotide For Use In A Method Of Preventing And/or Treating An Ophthalmic Disease App 20170314025 - JASCHINSKI; Frank ; et al.	2017-11-02
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease Grant 9,688,988 - Jaschinski , et al. June 27, 2	2017-06-27
Modified Tgf-beta Oligonucleotides App 20160076037 - JASCHINSKI; Frank ; et al.	2016-03-17
Modified Tgf-beta2 Oligonucleotides App 20160060632 - JASCHINSKI; Frank ; et al.	2016-03-03
Modified Tgf-beta Oligonucleotide For Use In A Method Of Preventing And/or Treating An Ophthalmic Disease App 20160040167 - JASCHINSKI; Frank ; et al.	2016-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.